Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
ACTION Trial- Adoptive Cellular Therapy Following Dose-Intensified Temozolomide in Newly-Diagnosed Pediatric High-Grade Gliomas (Phase I)
Elevated NF-kB Signaling in Breast Cancers of African American Women
MCC 18613 Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
MCC 18613, Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
MCC 19487 A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with 5-Azacytidine in Patients with Recurrent, Resectable Osteosarcoma
MCC 20320 Blood Based Biomarkers for Minimal Residual Disease Detection in Pediatric Sarcomas
MCC 20320 Blood Based Biomarkers for Minimal Residual Disease Detection in Pediatric Sarcomas
MCC 20339 Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma
Sequence Variation in MtDNA and Extreme Survival in Glioblastoma
Southeast Region Case-Control Study of Adult Glioma
UAB 1360: Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-Muscle-Invasive Transitional Cell Bladder Cancer
